| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 988-993, Copyright © 1981 by Endocrine Society
ARTICLES |
JA Amico, SM Seif and AG Robinson
RIA for the measurement of oxytocin in human plasma is described. Extraction of oxytocin from larger peptides in plasma used acetone precipitation with a 75% +/- 2 SEM recovery of oxytocin. Nonspecific binding of the assay was less than 4%, and the minimum level of detection was 0.2 microunits/tube. No cross-reactivity was noted with neurophysins, arginine, or lysine vasopressin. The mean basal level (+/- SEM) of oxytocin in men was 1.80 +/- 0.07 microunits/ml and was not different in normal women (1.71 +/- 0.07 microunits/ml). Changes in posture had no effect on the levels of oxytocin. Samples obtained every 15 min over 4 h showed no pulsatile secretion of oxytocin. In women chronically receiving estrogen as an oral contraceptive, oxytocin was greater than normal, (4.59 +/- 0.51 microunits/ml; P less than 0.01). Estrogen-stimulated neurophysin was also elevated (8.45 +/- 1.99 ng/ml; P less than 0.005). Acute ingestion of estrogen caused an increase in the level of oxytocin in plasma by 12 h and a concomitant elevation of estrogen-stimulated neurophysin. When the neurophysin was isolated from plasma obtained from a subject after ingestion of estrogen, the neurophysin from plasma comigrated on a polyacrylamide gel with a human pituitary standard of estrogen-stimulated neurophysin. In the studies in which neurophysin was elevated, the correlation between the level of oxytocin and the level of estrogen-stimulated neurophysin in plasma was significant (P less than 0.01). The observation that estrogen administration stimulates the release of oxytocin and estrogen- stimulated neurophysin provides additional evidence that this neurophysin is the oxytocin-neurophysin of man.
This article has been cited by other articles:
![]() |
H. Sakamoto, K.-i. Matsuda, K. Hosokawa, M. Nishi, J. F. Morris, E. R. Prossnitz, and M. Kawata Expression of G Protein-Coupled Receptor-30, a G Protein-Coupled Membrane Estrogen Receptor, in Oxytocin Neurons of the Rat Paraventricular and Supraoptic Nuclei Endocrinology, December 1, 2007; 148(12): 5842 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
B C Nephew, J Amico, H M Cai, A M Walker, and R S Bridges Intracerebroventricular administration of the prolactin (PRL) receptor antagonist, S179D PRL, disrupts parturition in rats Reproduction, July 1, 2007; 134(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Somponpun and C. D. Sladek Osmotic Regulation of Estrogen Receptor-{beta} in Rat Vasopressin and Oxytocin Neurons J. Neurosci., May 15, 2003; 23(10): 4261 - 4269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Somponpun and C. D. Sladek Role of Estrogen Receptor-{beta} in Regulation of Vasopressin and Oxytocin Release in Vitro Endocrinology, August 1, 2002; 143(8): 2899 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System Physiol Rev, July 1, 2001; 81(3): 1197 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Kowalski, L. Diveky, R. Mehendale, M. Parsons, and L. Wilson Jr. Effect of pregnancy on the metabolic clearance rate and the volume of distribution of oxytocin in the baboon Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E791 - E795. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |